Cardiac rehab for people with high genetic risk of arrhythmogenic cardiomyopathy
Part of Genetic & congenital, Heart & circulation clinical trials.
This study tests a cardiac rehabilitation program designed for people with a high genetic risk of arrhythmogenic cardiomyopathy (a condition that affects the heart's rhythm and structure). It aims to see if a safe, supervised exercise plan can help improve heart function and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with arrhythmogenic cardiomyopathy (ACM) based on the latest criteria.
- Imaging tests (echocardiogram or MRI) show problems with your heart's left or right ventricle, such as reduced pumping ability or scarring.
- You have a confirmed genetic variant in one of these genes: LMNA, DSP, FLNC, TMEM43, PLN, or DES.
- You have been stable for at least 3 months with no hospital stays, serious heart rhythm problems, or shocks from an ICD.
- You are not currently doing competitive or high-intensity sports or exercise programs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry collects information from people with a specific heart condition called arrhythmogenic cardiomyopathy who have an ICD (a device that helps control heart rhythm). The goal is to learn more about heart rhythm problems and how the ICD responds.
This study looks at how exercise affects heart rhythm in people with ARVC, a genetic heart condition. Participation involves supervised exercise sessions and heart monitoring to better understand safe activity levels.
This trial evaluates early prevention and treatment strategies for arrhythmogenic cardiomyopathy (ACM), a heart condition that can cause abnormal heart rhythms. It aims to improve care by using advanced tests like heart imaging and genetic sequencing to guide treatment.
This study looks at whether a 5-week supervised exercise and education program can help people with a specific type of heart amyloidosis (ATTR) feel better and improve their heart function. It will check your exercise ability and heart health before and after the program.
This study looks at the risk of a fast heart rhythm (ventricular tachycardia) in people with genetic heart muscle diseases. It tests whether having a specific genetic change affects the success of a heart ablation procedure.
This trial tests a home-based program to help young people (ages 8 to 25) with congenital heart disease get stronger and feel better through safe, guided exercise. It's designed for those whose heart doctor has already recommended cardiac rehab.
Hear when a new Arrhythmogenic Cardiomyopathy (AC, ARVD/C) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.